海外の治験の状況「%E8%84%B3%E5%8D%92%E4%B8%AD」での検索結果
6814件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not Recruiting
- Train the sedentary brain: move smart to reduce the risk of dementia. Sub study: Alternating aerobic and strength exercise in APOEe4 carriers and non-carriers in early stage dementia: effects and dose-response relation.
- Dementia, Alzheimer's Disesae, cognitive impairment, apolipoprotein E4, exercise, physical activity - dementie, ziekte van Alzheimer, cognitieve achteruitgang, apolipoproteine E4, fysieke activiteit, beweging
- The Netherlands
- 2015-03-02
Not recruiting
- Safety, Tolerability and Pharmacokinetics of Estetrol (E4) After Single and Multiple Oral Doses in Healthy Female Volunteers
- Contraception;Menopause;Contraception;Menopause;Contraception;Menopause;Contraception;Menopause
- Bulgaria
- 2017-03-06
Not Recruiting
- A safety and tolerability study of Sodium Copper Chlorophyllin in healthy, adult human male subjects.
- ADULT, HUMAN MALE SUBJECTS
- India
- 2018-09-04
Not recruiting
- Effects of b3-Adrenergic Receptor Agonists on Brown Adipose Tissue
- Obesity;Obesity;Obesity
- United States
- 2013-01-29
Not recruiting
- The COMBINE Study: The CKD Optimal Management With BInders and NicotinamidE
- Chronic Kidney Disease;Chronic Kidney Disease;Chronic Kidney Disease;Chronic Kidney Disease
- United States
- 2014-07-28
Not Recruiting
- Anticancer activity of nicotinamide on lung cancer
- ;Neoplasms
- Korea, Republic of
- 2015-05-06
Not Recruiting
- A clinical study for determination of effect of two investigational products, papuduo and papulex compared to its placebo in volunteers with acne prone skin.
- Subjects(male and female both) presenting mild to moderate acne
- India, Mauritius
- 2015-04-24
Not recruiting
- Anticancer Activity of Nicotinamide on Lung Cancer
- Non-Small-Cell Lung Carcinoma
- Korea, Republic of
- 2015-04-03
Not Recruiting
- Efficacy and tolerability of nicotinamide as add-on therapy compared to placebo in dialysis-dependent patients with elevated phosphat level
- Dialysis-dependent patients with hyperphosphatemia MedDRA version: 19.0 Level: LLT Classification code 10020712 Term: Hyperphosphatemia System Organ Class: 100000004861 ;Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]
- Austria, Germany, Hungary, Poland
- 2013-07-04
Not recruiting
- Clinical Trial of 4% Niacinamide Versus 0.05% Desonide for the Treatment of Axillar Hyperpigmentation
- Hyperpigmentation
- Mexico
- 2012-02-21